IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good,
the bad, and the ugly. It has been increasingly apparent that wasting and cardiovascular …

In the past few years, inflammation has emerged as a major driving force of atherosclerotic
lesion development. It is now well-established that from early lesion to vulnerable plaque …

Atherosclerosis is a chronic inflammatory disease that may ultimately lead to local
proteolysis, plaque rupture, and thrombotic vascular disease, resulting in myocardial …

Atherosclerosis is no longer considered a disorder due to abnormalities in lipid metabolism.
In fact, the inciting event of atherosclerosis is likely an inflammatory insult that occurs …

Objective: Tumor necrosis factor-α (TNFα) is a pleiotropic cytokine exerting both
inflammatory and cell death modulatory activity, and is thought to play a role in the …

Vasa vasorum (VV) neovascularization is a key feature of early atherosclerosis and adds
substantial endothelial exchange-surface to the coronary vessel wall. Thus, it is conceivable …

Thalidomide and its immunomodulatory imide drugs (IMiDs) analogues CC-5013
(Revlimid™, Lenalidomide) and CC-4047 (Actimid™, Pomalidomide) have been used as …

Plaque progression in atherosclerosis is closely connected to angiogenesis due to vasa
vasorum (VV) growth. Objective of this study was to determine the unknown long-term effect …

Cardiovascular oncology: exploring the effects of targeted c... : Current Opinion in
Lipidology Cardiovascular oncology: exploring the effects of targeted cancer therapies on …

Damage to peripheral arteries by the atherosclerotic process accounts for about 3% of the
world's population, which puts this problem in the category of major social problems …